Skip to main content
Clinical Trials/NL-OMON50918
NL-OMON50918
Recruiting
Not Applicable

Fluorescence guided surgery for intra-operative detection of meningioma using Bevacizumab-IRDye800CW - Fluorescence guided surgery of meningioma using Bevacizumab-800CW (LUMINA)

niversitair Medisch Centrum Groningen0 sites19 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
19
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age \>\= 18 years;
  • \- Patients with convexity or sphenoid wing meningioma determined by
  • preoperative imaging, e.g. MRI and/or CT;
  • \- Scheduled to undergo elective resection at the UMCG as part of the standard
  • preoperative work\- up;
  • \- Mentally competent person who is able and willing to comply with study
  • procedures;
  • \- Signed written informed consent.

Exclusion Criteria

  • \- Has been injected with another Investigational Medicinal Product (IMP) within
  • the past month;
  • \- Concomitant malignancies, except for adequately treated basocellular
  • carcinoma of the skin or in situ carcinoma of the cervix uteri. Subjects with
  • prior malignancies must be disease\-free for at least five years;
  • \- Previous allergic reaction to Bevacizumab;
  • \- Medical or psychiatric conditions that compromise the patient\*s ability to
  • give informed consent;
  • \- Pregnant or lactating women. During standard of care, pregnancy is a
  • contraindication for elective (neuro)surgical procedures. Therefore, the

Outcomes

Primary Outcomes

Not specified

Similar Trials